Repligen (RGEN)

Add to Watchlists
Create an Alert
33.14 -1.61  -4.63% NASDAQ Apr 27, 1:04PM BATS Real time Currency in USD
View Full Chart
RGEN Price Chart
View All Events

RGEN Events

Date Type Description
05/21/2015 Misc Repligen Corp 2014 Annual General Meeting
03/13/2015 08:30 EDT Misc Repligen Corp Fourth Quarter Earnings Conference Call in 2014
03/13/2015 Earnings Repligen Corp Fourth Quarter Earnings in 2014 Release
11/06/2014 08:30 EST Misc Q3 2014 Repligen Corp Earnings Conference Call
11/06/2014 Earnings Q3 2014 Repligen Corp Earnings Results
08/11/2014 08:30 EDT Misc Q2 2014 Repligen Corp Earnings Conference Call
08/11/2014 Earnings Q2 2014 Repligen Corp Earnings Results
06/03/2014 Misc Repligen Acquires Bioprocessing Business of Refine Technology
05/08/2014 08:30 EDT Misc Q1 2014 Repligen Corp Earnings Conference Call
05/08/2014 Earnings Q1 2014 Repligen Corp Earnings Results
View All Performance Charts

RGEN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Repligen is up 111.6% over the last year vs S&P 500 Total Return up 14.73%, Anacor Pharmaceuticals up 262.9%, and GlycoMimetics down 37.86%.

Get Quote for

PDF Report for RGEN

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download RGEN Pro Report PDF
Advertisement

RGEN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.repligen.com
  • IR Website: http://corporate.repligen.com/corporateprofile.aspx?iid=4325751
  • HQ Country: United States
  • HQ State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: December 31, 2014
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Repligen Corp is a life sciences company engaged in the development, manufacture & sale of consumable bioprocessing products for life sciences companies & biopharmaceutical manufacturing companies. It also supplies growth factor products.

RGEN Excel Add-In Codes

  • Name: =YCI("RGEN","name")
  • Description: =YCI("RGEN","description")
  • Sector: =YCI("RGEN","sector")
  • Industry: =YCI("RGEN","industry")
  • Est. Current Fiscal Year End: =YCI("RGEN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.